Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Cytek Biosciences, Inc. cash on hand for the quarter ending December 31, 2025 were 90.9M, a 7.97% decrease year-over-year.
- Cytek Biosciences, Inc. cash on hand for 2025 were 90.9M, a 7.97% decrease from 2024.
- Cytek Biosciences, Inc. cash on hand for 2024 were 98.7M, a 40.99% decrease from 2023.
- Cytek Biosciences, Inc. cash on hand for 2023 were 167.3M, a 43.59% decrease from 2022.
- Cytek Biosciences, Inc. cash on hand for 2022 were 296.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cytek Biosciences, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $91 |
| 2024 | $99 |
| 2023 | $167 |
| 2022 | $297 |
| 2021 | $365 |
| 2020 | $165 |
| Cytek Biosciences, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $91 |
| 2024-12-31 | $99 |
| 2023-12-31 | $167 |
| 2022-12-31 | $297 |
| 2021-12-31 | $365 |
| 2020-12-31 | $165 |
Cytek Biosciences, Inc. Cash on Hand — FAQ
Cytek Biosciences, Inc. (CTKB) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTKB's cash on hand history?
The chart and table above show Cytek Biosciences, Inc.'s cash on hand by year and by quarter, including the growth rate.